CELEXA Drug Patent Profile
✉ Email this page to a colleague
When do Celexa patents expire, and when can generic versions of Celexa launch?
Celexa is a drug marketed by Forest Labs and Abbvie and is included in two NDAs.
The generic ingredient in CELEXA is citalopram hydrobromide. There are fifty-six drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the citalopram hydrobromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Celexa
A generic version of CELEXA was approved as citalopram hydrobromide by AUROBINDO on October 28th, 2004.
Summary for CELEXA
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 216 |
Clinical Trials: | 53 |
Patent Applications: | 4,172 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CELEXA |
What excipients (inactive ingredients) are in CELEXA? | CELEXA excipients list |
DailyMed Link: | CELEXA at DailyMed |
Recent Clinical Trials for CELEXA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Western University, Canada | N/A |
Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 |
Mayo Clinic |
Pharmacology for CELEXA
Drug Class | Serotonin Reuptake Inhibitor |
Mechanism of Action | Serotonin Uptake Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for CELEXA
US Patents and Regulatory Information for CELEXA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Forest Labs | CELEXA | citalopram hydrobromide | SOLUTION;ORAL | 021046-001 | Dec 22, 1999 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbvie | CELEXA | citalopram hydrobromide | TABLET;ORAL | 020822-003 | Jul 17, 1998 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Abbvie | CELEXA | citalopram hydrobromide | TABLET;ORAL | 020822-001 | Apr 27, 2000 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Abbvie | CELEXA | citalopram hydrobromide | TABLET;ORAL | 020822-002 | Jul 17, 1998 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Abbvie | CELEXA | citalopram hydrobromide | TABLET;ORAL | 020822-004 | Jul 17, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |